Expert Review of Molecular Diagnostics 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease
Expert Rev Mol Diagn. 2023 Aug 1:1-12. doi: 10.1080/14737159.2023.2242779. Online ahead of print.ABSTRACTINTRODUCTION: The non-invasive identification of liver fibrosis related to Non-Alcoholic Fatty Liver Disease is crucial for risk-stratification of patients. Currently, the reference standard to stage hepatic fibrosis relies on liver biopsy, but multiple approaches are developed to allow for non-invasive diagnosis and risk stratification. Non-invasive tests, including blood-based scores and vibration-controlled transient elastography, have been widely validated and represent a good surrogate for risk stratification accor...
Source: Expert Review of Molecular Diagnostics - July 28, 2023 Category: Laboratory Medicine Authors: Angelo Armandi Maurice Michel Kamela Gjini Tilman Emrich Elisabetta Bugianesi Jorn M Schattenberg Source Type: research
One biomarker does not fit all: tailoring anti-infective therapy through utilization of procalcitonin and other specific biomarkers
Expert Rev Mol Diagn. 2023 Jul 31:1-14. doi: 10.1080/14737159.2023.2242782. Online ahead of print.ABSTRACTINTRODUCTION: Considering the ongoing increase in antibiotic resistance, the importance of judicious use of antibiotics through reduction of exposure is crucial. Adding procalcitonin (PCT) and other biomarkers to pathogen-specific tests may help to further improve antibiotic therapy algorithms and advance antibiotic stewardship programs to achieve these goals.AREAS COVERED: In recent years, several trials have investigated the inclusion of biomarkers such as PCT into clinical decision-making algorithms. For adult patie...
Source: Expert Review of Molecular Diagnostics - July 28, 2023 Category: Laboratory Medicine Authors: Lennart Essmann Yannick Wirz Claudia Gregoriano Philipp Schuetz Source Type: research
Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease
Expert Rev Mol Diagn. 2023 Aug 1:1-12. doi: 10.1080/14737159.2023.2242779. Online ahead of print.ABSTRACTINTRODUCTION: The non-invasive identification of liver fibrosis related to Non-Alcoholic Fatty Liver Disease is crucial for risk-stratification of patients. Currently, the reference standard to stage hepatic fibrosis relies on liver biopsy, but multiple approaches are developed to allow for non-invasive diagnosis and risk stratification. Non-invasive tests, including blood-based scores and vibration-controlled transient elastography, have been widely validated and represent a good surrogate for risk stratification accor...
Source: Expert Review of Molecular Diagnostics - July 28, 2023 Category: Laboratory Medicine Authors: Angelo Armandi Maurice Michel Kamela Gjini Tilman Emrich Elisabetta Bugianesi Jorn M Schattenberg Source Type: research
One biomarker does not fit all: tailoring anti-infective therapy through utilization of procalcitonin and other specific biomarkers
Expert Rev Mol Diagn. 2023 Jul 31:1-14. doi: 10.1080/14737159.2023.2242782. Online ahead of print.ABSTRACTINTRODUCTION: Considering the ongoing increase in antibiotic resistance, the importance of judicious use of antibiotics through reduction of exposure is crucial. Adding procalcitonin (PCT) and other biomarkers to pathogen-specific tests may help to further improve antibiotic therapy algorithms and advance antibiotic stewardship programs to achieve these goals.AREAS COVERED: In recent years, several trials have investigated the inclusion of biomarkers such as PCT into clinical decision-making algorithms. For adult patie...
Source: Expert Review of Molecular Diagnostics - July 28, 2023 Category: Laboratory Medicine Authors: Lennart Essmann Yannick Wirz Claudia Gregoriano Philipp Schuetz Source Type: research
Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease
Expert Rev Mol Diagn. 2023 Aug 1:1-12. doi: 10.1080/14737159.2023.2242779. Online ahead of print.ABSTRACTINTRODUCTION: The non-invasive identification of liver fibrosis related to Non-Alcoholic Fatty Liver Disease is crucial for risk-stratification of patients. Currently, the reference standard to stage hepatic fibrosis relies on liver biopsy, but multiple approaches are developed to allow for non-invasive diagnosis and risk stratification. Non-invasive tests, including blood-based scores and vibration-controlled transient elastography, have been widely validated and represent a good surrogate for risk stratification accor...
Source: Expert Review of Molecular Diagnostics - July 28, 2023 Category: Laboratory Medicine Authors: Angelo Armandi Maurice Michel Kamela Gjini Tilman Emrich Elisabetta Bugianesi Jorn M Schattenberg Source Type: research
One biomarker does not fit all: tailoring anti-infective therapy through utilization of procalcitonin and other specific biomarkers
Expert Rev Mol Diagn. 2023 Jul 31:1-14. doi: 10.1080/14737159.2023.2242782. Online ahead of print.ABSTRACTINTRODUCTION: Considering the ongoing increase in antibiotic resistance, the importance of judicious use of antibiotics through reduction of exposure is crucial. Adding procalcitonin (PCT) and other biomarkers to pathogen-specific tests may help to further improve antibiotic therapy algorithms and advance antibiotic stewardship programs to achieve these goals.AREAS COVERED: In recent years, several trials have investigated the inclusion of biomarkers such as PCT into clinical decision-making algorithms. For adult patie...
Source: Expert Review of Molecular Diagnostics - July 28, 2023 Category: Laboratory Medicine Authors: Lennart Essmann Yannick Wirz Claudia Gregoriano Philipp Schuetz Source Type: research
Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease
Expert Rev Mol Diagn. 2023 Aug 1:1-12. doi: 10.1080/14737159.2023.2242779. Online ahead of print.ABSTRACTINTRODUCTION: The non-invasive identification of liver fibrosis related to Non-Alcoholic Fatty Liver Disease is crucial for risk-stratification of patients. Currently, the reference standard to stage hepatic fibrosis relies on liver biopsy, but multiple approaches are developed to allow for non-invasive diagnosis and risk stratification. Non-invasive tests, including blood-based scores and vibration-controlled transient elastography, have been widely validated and represent a good surrogate for risk stratification accor...
Source: Expert Review of Molecular Diagnostics - July 28, 2023 Category: Laboratory Medicine Authors: Angelo Armandi Maurice Michel Kamela Gjini Tilman Emrich Elisabetta Bugianesi Jorn M Schattenberg Source Type: research
One biomarker does not fit all: tailoring anti-infective therapy through utilization of procalcitonin and other specific biomarkers
Expert Rev Mol Diagn. 2023 Jul 31:1-14. doi: 10.1080/14737159.2023.2242782. Online ahead of print.ABSTRACTINTRODUCTION: Considering the ongoing increase in antibiotic resistance, the importance of judicious use of antibiotics through reduction of exposure is crucial. Adding procalcitonin (PCT) and other biomarkers to pathogen-specific tests may help to further improve antibiotic therapy algorithms and advance antibiotic stewardship programs to achieve these goals.AREAS COVERED: In recent years, several trials have investigated the inclusion of biomarkers such as PCT into clinical decision-making algorithms. For adult patie...
Source: Expert Review of Molecular Diagnostics - July 28, 2023 Category: Laboratory Medicine Authors: Lennart Essmann Yannick Wirz Claudia Gregoriano Philipp Schuetz Source Type: research
Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease
Expert Rev Mol Diagn. 2023 Jul 28. doi: 10.1080/14737159.2023.2242779. Online ahead of print.ABSTRACTINTRODUCTION: The non-invasive identification of liver fibrosis related to Non-Alcoholic Fatty Liver Disease is crucial for risk-stratification of patients. Currently, the reference standard to stage hepatic fibrosis relies on liver biopsy, but multiple approaches are developed to allow for non-invasive diagnosis and risk stratification. Non-invasive tests, including blood-based scores and vibration-controlled transient elastography, have been widely validated and represent a good surrogate for risk stratification according...
Source: Expert Review of Molecular Diagnostics - July 28, 2023 Category: Laboratory Medicine Authors: Angelo Armandi Maurice Michel Kamela Gjini Tilman Emrich Elisabetta Bugianesi J örn M Schattenberg Source Type: research
One biomarker does not fit all: tailoring anti-infective therapy through utilization of procalcitonin and other specific biomarkers
Expert Rev Mol Diagn. 2023 Jul 31:1-14. doi: 10.1080/14737159.2023.2242782. Online ahead of print.ABSTRACTINTRODUCTION: Considering the ongoing increase in antibiotic resistance, the importance of judicious use of antibiotics through reduction of exposure is crucial. Adding procalcitonin (PCT) and other biomarkers to pathogen-specific tests may help to further improve antibiotic therapy algorithms and advance antibiotic stewardship programs to achieve these goals.AREAS COVERED: In recent years, several trials have investigated the inclusion of biomarkers such as PCT into clinical decision-making algorithms. For adult patie...
Source: Expert Review of Molecular Diagnostics - July 28, 2023 Category: Laboratory Medicine Authors: Lennart Essmann Yannick Wirz Claudia Gregoriano Philipp Schuetz Source Type: research
Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease
Expert Rev Mol Diagn. 2023 Jul 28. doi: 10.1080/14737159.2023.2242779. Online ahead of print.ABSTRACTINTRODUCTION: The non-invasive identification of liver fibrosis related to Non-Alcoholic Fatty Liver Disease is crucial for risk-stratification of patients. Currently, the reference standard to stage hepatic fibrosis relies on liver biopsy, but multiple approaches are developed to allow for non-invasive diagnosis and risk stratification. Non-invasive tests, including blood-based scores and vibration-controlled transient elastography, have been widely validated and represent a good surrogate for risk stratification according...
Source: Expert Review of Molecular Diagnostics - July 28, 2023 Category: Laboratory Medicine Authors: Angelo Armandi Maurice Michel Kamela Gjini Tilman Emrich Elisabetta Bugianesi J örn M Schattenberg Source Type: research
One biomarker does not fit all: tailoring anti-infective therapy through utilization of procalcitonin and other specific biomarkers
Expert Rev Mol Diagn. 2023 Jul 28. doi: 10.1080/14737159.2023.2242782. Online ahead of print.ABSTRACTINTRODUCTION: Considering the ongoing increase in antibiotic resistance, the importance of judicious use of antibiotics through reduction of exposure is crucial. Adding procalcitonin (PCT) and other biomarkers to pathogen-specific tests may help to further improve antibiotic therapy algorithms and advance antibiotic stewardship programs to achieve these goals.AREAS COVERED: In recent years, several trials have investigated the inclusion of biomarkers such as PCT into clinical decision-making algorithms. For adult patients, ...
Source: Expert Review of Molecular Diagnostics - July 28, 2023 Category: Laboratory Medicine Authors: Lennart Essmann Yannick Wirz Claudia Gregoriano Philipp Schuetz Source Type: research
Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease
Expert Rev Mol Diagn. 2023 Jul 28. doi: 10.1080/14737159.2023.2242779. Online ahead of print.ABSTRACTINTRODUCTION: The non-invasive identification of liver fibrosis related to Non-Alcoholic Fatty Liver Disease is crucial for risk-stratification of patients. Currently, the reference standard to stage hepatic fibrosis relies on liver biopsy, but multiple approaches are developed to allow for non-invasive diagnosis and risk stratification. Non-invasive tests, including blood-based scores and vibration-controlled transient elastography, have been widely validated and represent a good surrogate for risk stratification according...
Source: Expert Review of Molecular Diagnostics - July 28, 2023 Category: Laboratory Medicine Authors: Angelo Armandi Maurice Michel Kamela Gjini Tilman Emrich Elisabetta Bugianesi J örn M Schattenberg Source Type: research
One biomarker does not fit all: tailoring anti-infective therapy through utilization of procalcitonin and other specific biomarkers
Expert Rev Mol Diagn. 2023 Jul 28. doi: 10.1080/14737159.2023.2242782. Online ahead of print.ABSTRACTINTRODUCTION: Considering the ongoing increase in antibiotic resistance, the importance of judicious use of antibiotics through reduction of exposure is crucial. Adding procalcitonin (PCT) and other biomarkers to pathogen-specific tests may help to further improve antibiotic therapy algorithms and advance antibiotic stewardship programs to achieve these goals.AREAS COVERED: In recent years, several trials have investigated the inclusion of biomarkers such as PCT into clinical decision-making algorithms. For adult patients, ...
Source: Expert Review of Molecular Diagnostics - July 28, 2023 Category: Laboratory Medicine Authors: Lennart Essmann Yannick Wirz Claudia Gregoriano Philipp Schuetz Source Type: research
Promotor methylation in ocular surface squamous neoplasia development: epigenetics implications in molecular diagnosis
Expert Rev Mol Diagn. 2023 Jul 26. doi: 10.1080/14737159.2023.2240238. Online ahead of print.ABSTRACTINTRODUCTION: Cancer is heavily influenced by epigenetic mechanisms that include DNA methylation, histone modifications and non-coding RNA. A considerable proportion of human malignancies are believed to be associated with global DNA hypomethylation, with localized hypermethylation at promoters of certain genes.AREA COVERED: The present review aims to emphasize on recent investigations on the epigenetic landscape of ocular surface squamous neoplasia, that could be targeted/explored using novel approaches such as personalize...
Source: Expert Review of Molecular Diagnostics - July 26, 2023 Category: Laboratory Medicine Authors: Kourosh Shahraki Kianoush Shahraki Paria Ghasemi Boroumand Roghayeh Sheervalilou Source Type: research
